Cargando…
The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan
BACKGROUND: One of the main goals of the post-2015 global tuberculosis (TB) strategy is that no families affected by TB face catastrophic costs. We revised an existing TB patient cost measurement tool to specifically also measure multi-drug resistant (MDR) TB patients’ costs and applied it in Ethiop...
Autores principales: | van den Hof, Susan, Collins, David, Hafidz, Firdaus, Beyene, Demissew, Tursynbayeva, Aigul, Tiemersma, Edine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011357/ https://www.ncbi.nlm.nih.gov/pubmed/27595779 http://dx.doi.org/10.1186/s12879-016-1802-x |
Ejemplares similares
-
Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study
por: van Kampen, Sanne Christine, et al.
Publicado: (2015) -
Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study
por: van Kampen, Sanne Christine, et al.
Publicado: (2015) -
Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis
por: Mafirakureva, Nyashadzaishe, et al.
Publicado: (2022) -
Comparison of Xpert MTB/RIF Ultra Results of Stool and Sputum in Children with Presumptive Tuberculosis in Southern Ethiopia
por: Babo, Yohannes, et al.
Publicado: (2023) -
Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia
por: Ruru, Yacob, et al.
Publicado: (2018)